Card set for promoting memorization of pharmaceutical information
The card set facilitates deep understanding of drug relationships and clinical usage through game-based learning, addressing the limitations of conventional memorization methods by incorporating drug design and treatment policies, enhancing medical knowledge retention.
Patent Information
- Application Number
- JP2024098357
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-05-31
- Publication Date
- 2025-12-11
- Estimated Expiration
- 2044-05-31
AI Technical Summary
Existing methods for memorizing drug names and efficacy fail to adequately convey the relationship between pharmaceuticals' exterior design, usage methods, and clinical guidelines, limiting understanding and application in medical settings.
A card set comprising drug cards with blank spaces for writing original and generic drug names, product design mimics, and color-coding for efficacy, along with event cards for treatment policies, facilitating a game-based learning approach.
Enhances understanding of drug relationships and clinical usage through tactile and visual memorization, aligning with clinical guidelines, and preventing medical incidents by promoting knowledge acquisition.
Smart Images

Figure 2025181560000001_ABST
Abstract
Description
[Technical Field]
[0001] The present invention relates to a card set for learning about the characteristics of medicines through playing with the cards. [Background technology]
[0002] The names of pharmaceutical ingredients are generally clearly indicated as generic drug names, but there may be multiple original or generic drug names that are the product names for generic drug names. Understanding these names, the design of the product's appearance, and the efficacy and effects of the pharmaceutical is extremely important for medical professionals such as doctors and pharmacists as a preventative measure against incidents and accidents.
[0003] To address these issues, medical professionals in the medical field rely heavily on their own efforts to improve themselves, and each individual must research and fully understand the characteristics of pharmaceuticals and then memorize them.
[0004] Conventionally, a method of memorizing drug names and efficacy using mnemonics and the like has been known from books that compile them, as described in the following Non-Patent Document 1. While this book allows users to understand the names of original drugs that correspond to generic drug names, it is not necessarily sufficient for understanding the design of the product's exterior or the usage methods that correspond to various clinical guidelines. [Prior art documents] [Non-patent literature]
[0005] [Non-Patent Document 1] Hideki Kasahara, "Quickly Memorize! 596 Drug Names," Jiho Publishing, February 1, 2007 Summary of the Invention [Problem to be solved by the invention]
[0006] The present invention has been made in consideration of the above-mentioned problems, and aims to provide a card set and a playing method that allows players to acquire knowledge about pharmaceuticals that will be useful in actual medical settings by deepening their understanding of the relationship between the product's exterior design, the relationship between pharmaceuticals and each other, and how to use them in accordance with various clinical guidelines, rather than simply memorizing pharmaceutical names in a one-to-one correspondence. [Means for solving the problem]
[0007] The cards of the present invention are composed of a generic name of a drug, a blank space for writing the name of the original drug or the generic drug corresponding to the generic name, and a design portion that mimics the outline of the product shape to understand the design of each product. The cards are also color-coded according to the efficacy and characteristics of the drug, and the relationship between drugs.
[0008] Furthermore, the card set of the present invention includes event cards for incorporating disease treatment policies corresponding to each medical treatment guideline as game rules. [Effects of the Invention]
[0009] The card set of the present invention is composed of blank spaces for writing the names of original and generic drugs, and a design section that mimics the outline of the product shape to help understand the design of each product, making it possible to accommodate products such as original and generic drugs for which there are multiple versions for each generic drug name.
[0010] Thus, with the card set of the present invention, not only can the efficacy and characteristics corresponding to the generic names of the medicines written on it be seen at a glance, but the player can also write in the blank spaces any name of an original or generic medicine used in actual medical practice, and further, by coloring the design part that mimics the outline of the product's exterior in a way that evokes the above design or writing in the tablet's engraving, it is possible to create original cards that are expected to have a memorization effect that utilizes both tactile and visual senses.
[0011] In addition, the cards are color-coded according to the efficacy and characteristics of the medicines, making it possible to simultaneously understand the relationships between medicines.
[0012] If these drug cards and event cards are provided to incorporate treatment policies in accordance with clinical guidelines for each disease as game rules, repeatedly playing the game using these cards will have the effect of teaching knowledge about drugs that will be useful in actual medical settings. [Brief explanation of the drawings]
[0013] [Figure 1] 1 is a schematic diagram showing a representative example of a medicine card according to one embodiment of the present invention. [Figure 2] FIG. 2 is a schematic diagram showing a representative example of an event card in the embodiment. DETAILED DESCRIPTION OF THE INVENTION
[0014] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A card set according to the present invention will be described in detail below based on an embodiment shown in the drawings.
[0015] Figure 1 is a schematic diagram showing a drug card according to one embodiment of the present invention. As shown in this figure, the drug card of this embodiment compiles various information about drugs, and the card set alone can serve as a play toy. However, by using it in conjunction with an event card as shown in Figure 2, it can be used as a play toy that reflects the drug usage method in accordance with the treatment guidelines for each disease.
[0016] As shown in Figure 1, the drug card includes an area for displaying the drug classification (2·8), an area for displaying a design that mimics the product design (3·9), an area for writing the name of the original drug or the generic drug (4·10), an area for displaying the generic name of the drug (5·11), an area for displaying information about the drug (e.g., for highly potent drugs) (6), and an area for displaying the efficacy and effects of the drug (7).
[0017] There are no particular restrictions on the types of drug cards included in the card set, but the optimal number can be determined by grouping together drugs with the same efficacy or by selecting from representative drugs listed in various treatment guidelines for each disease, etc., by increasing or decreasing the number of card types as appropriate.
[0018] As shown in FIG. 1, the "number area required by the game rules" in 1 of the pharmaceutical card embodiment A is a supplementary area used depending on the content of the game played with the card set.
[0019] As shown in Figure 1, the "drug classification display area" indicated by symbols 2 and 8 is used for classification by drug efficacy. In Example A, classification is performed by rank (strength) of topical steroid medications (strongest, very strong, strong, medium, weak). In Example B, classification is performed by generation of antihistamines, which are antiallergic drugs.
[0020] As shown in Figure 1, the "product design area" (3·9) can be colored to match the product design corresponding to the generic drug name listed in the "general drug name display area" (5·11) that the player wants to memorize. Also, the tablet design area can be engraved.
[0021] As shown in Figure 1, in the "Original Drug Name or Generic Drug Name Entry Area" at 4·10, the player can enter the original drug name or generic drug name of the product that corresponds to the generic drug name written in the "Generic Drug Name Display Area" at 5·11 that the player wants to memorize.
[0022] As shown in Figure 1, the "non-proprietary drug name display area" (5-11) uses the Japanese Accepted Names for Pharmaceuticals (JAN) as defined by the Ministry of Health, Labor and Welfare, but the International Nonproprietary Name (INN) as defined by the World Health Organization may also be used.
[0023] As shown in Figure 1, the "pharmaceutical information display area (e.g., powerful drug)" indicated by reference numeral 6 can display various characteristics related to the pharmaceutical. In this embodiment, the word "powerful" is used to indicate a powerful drug, but it can also indicate poisons, narcotics, stimulants, psychotropic drugs, and other drugs used in pharmaceutical regulatory categories. Other information that may be displayed includes storage instructions, risk to pregnant and nursing mothers, whether or not the drug is suitable for driving, precautions for the elderly, warnings, contraindications, and pharmacokinetics.
[0024] As shown in Figure 1, the "drug efficacy display area" indicated by reference number 7 lists the efficacy of the drug as a major category. This area may also list the indications listed in the drug's package insert.
[0025] FIG. 2 is a schematic diagram of an embodiment of an event card for incorporating into the rules treatment policies in accordance with various treatment guidelines for diseases when playing a game using a card set of medicines.
[0026] In the "Event Card Effect Title Display Area" indicated by reference numerals 14 and 15 in FIG. 2, in addition to step-down and side effects, examples include severe, bacterial infection, infantile, hemorrhoids, etc., but are not limited to these.
[0027] The "Event Card Effect Description Display Area" for items 12 and 17 in Figure 2 describes effects that evoke usage methods in accordance with actual treatment plans. For example, item 12 "Step Down" evokes the idea of step-down therapy, in which topical steroid medications are gradually reduced in rank from strong to weak.
[0028] The designs shown in the "event card effect design display areas" denoted by reference numerals 13 and 16 in FIG. 2 may be pictures, photographs, or symbols, and the attributes are not particularly limited.
[0029] As described above, the drug cards and event cards included in the drug card set have been described using Figures 1 and 2, but the present invention is not limited to these. For example, the types of drugs are not limited to topical and oral medications, and various dosage forms such as injections, patches, liquids, and powders can be used.
[0030] The number of drug cards used in a card set is not particularly limited as long as it is plural, but the number of cards in a card set can be determined based on the classification of drugs, treatment guidelines for each disease, etc. Similarly, the number of event cards is not particularly limited.
[0031] The material used for the cards is not particularly limited, and the same materials and structures as those of conventionally known playing cards and cards used in various card games can be used. For example, preferred examples include plastic and paper with a special coating on the surface, which allow for modification of the information and coloring written in the area for writing the original drug name or generic drug name and the area for designing the product. Furthermore, these cards may have the same shape and size, or may have different shapes and sizes. [Example]
[0032] Next, an example of a game method using the above card set will be described.
[0033] In this example, 30 drug cards and 6 event cards were actually created. As described above, the drug cards are comprised of "numbers required by the game rules," "drug classification display area," "design area imitating the product design," "area for writing the original drug name or generic drug name," "drug generic name display area," "drug information display area," and "drug efficacy display area." Event cards are also comprised of "effect description display area," "effect design display area," and "effect title display area."
[0034] The main purpose of this card set is to learn the rank (strength) of topical steroid medications based on their generic names through play. Understanding the characteristics of these medications will encourage proper use of medications not only by medical professionals but also by general users.
[0035] Topical steroids used as medicines are ranked according to the symptoms and application site, and continued use of a topical steroid of an inappropriate rank for the symptoms and application site may result in side effects or affect symptom improvement.
[0036] The medication cards in this example are based on the Japanese Dermatological Association's "Guidelines for the Treatment of Atopic Dermatitis" and classify topical steroid medications into five color-coded levels: strongest (strongest), very strong (very strong), strong (strong), medium (normal), and weak (weak).
[0037] The event cards in this embodiment add depth to the game content by using as events matters that should be considered when actually using a topical steroid, such as step-down therapy, bacterial infection, infants, side effects, severe illness, and hemorrhoids.
[0038] In this embodiment, the player writes the product name they want to remember in the "Original Drug Name or Generic Drug Name Writing Area" at 4 in Figure 1, A on the pharmaceutical card, and similarly, the part of the design that resembles a white tube in the "Product Design Image Area" at 3 in Figure 1, A can be colored with a colored pen or the like, which has the effect of making it easier to recall the product.
[0039] The basic procedure for playing with the card set of this embodiment is to first shuffle the 30 medicine cards thoroughly and deal the same number to each player. One event card is dealt to each player.
[0040] Each player plays cards in order, starting with the weakest ranked topical steroid medication cards and working their way up to the stronger ranked cards. This process is repeated until the player who runs out of cards the fastest wins.
[0041] Each player can use an event card at any time during their turn.
[0042] In the early stages when you are not yet familiar with the game, you can play cards from the highest number to the lowest number by using the symbol 1 "Numbers required by the game rules" shown in Figure 1, A.
[0043] As explained above with reference to the embodiments, by using the pharmaceutical card set of the present invention, it is possible to simultaneously grasp the generic names of pharmaceuticals, the original drug names or generic drug names, the designs of the above products, and the relationships between pharmaceuticals through play. By incorporating these pharmaceutical card sets and treatment policies in accordance with each clinical guideline into the rules, it is possible to gain an understanding of knowledge that will be useful in actual medical settings.
[0044] Furthermore, the pharmaceutical card set of the present invention is expected to help prevent incidents and accidents that are likely to occur in the workplace by allowing people working in the same workplace to play while having conversations with each other. Furthermore, even when medical professionals with specialized knowledge about pharmaceuticals play with ordinary people, it is expected to have the effect of naturally learning pharmaceutical knowledge.
[0045] The topical steroid medication card set described in this example is merely an example, and it is possible to study many other drug classes, diseases, etc. in the same way as with these card sets. Furthermore, the game rules described above are merely an example, and various other games, such as poker or sevens, can be played.
[0046] Although one embodiment of the present invention has been described with reference to the attached drawings, it goes without saying that the present invention is not limited to these embodiments, and it is clear that various modified or altered examples can be conceived from the contents described in the claims, and it is understood that these also naturally fall within the scope of the present invention. [Industrial Applicability]
[0047] The card set of this invention is a toy that combines educational elements, aiming to help healthcare professionals have fun while understanding and memorizing knowledge that will be useful in actual medical settings.The card set of this invention can also be used as a teaching material to help not only healthcare professionals but also patients and their families who actually use medicines understand medicines. [Explanation of symbols]
[0048] A. Medication card (e.g., topical medication) B. Medication card (e.g., oral medication) C. Event card (e.g., treatment method) D. Event cards (e.g., side effects) 1. Numbers required by the game rules 2, 8... Drug classification display area 3, 9: Pattern area imitating the product design 4, 10: Name of original drug or generic drug 5, 11: General drug name display area 6. Information display area for pharmaceuticals (e.g., powerful drugs) 7. Drug efficacy and effect display area 12, 17 Event card effect description display area 13, 16 Event card effect image display area 14, 15 Event card effect title display area
Claims
1. This card set displays information about medicines and has a blank area for writing the generic name of the medicine, the name of the original medicine or the name of the generic medicine which is the product name of the generic name of the medicine, and a pattern area with an outline imitating the design of the appearance of the product.
2. The card set described in claim 1, characterized in that the card set is composed of a plurality of drug cards color-coded according to classification to represent the efficacy and effects and relationships of the drug, and a plurality of event cards that affect the content of the game when playing with the drug cards.
Citation Information
Patent Citations
Manufacturing and application of acupoint poker cards
CN111530060A
Element card and element-elementary particle card set
JP2010187948A
Card game teaching material for muscle start and stop learning
JP2012027428A
Small pieces set for learning and card set for learning
JP2015121749A
Acupoint (tsubo) memorization cards
JP3166633U